Application Value of Multimodal Magnetic Resonance Imaging in the Diagnosis of Atypical Hepatocellular Carcinoma

Abstract
Figure/Table
References
Related Citation (0)

Download: PDF (342 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective This study aims to explore the application value of multimodal magnetic resonance imaging (MRI) in the diagnosis of atypical hepatocellular carcinoma (HCC). Methods 80 patients with atypical HCC who were admitted to our hospital from August 2018 to February 2020 were selected as the research subjects. All patients underwent dynamic computed tomography (CT) enhancement scans,and then multimodal MRI scans,including an MRI plain scan,dynamic contrast-enhancement (DCE),and diffusion-weighted imaging (DWI). Then,the image data were analyzed. Results The diagnostic accuracy of the observation group (95.00%) was significantly higher than that of the control group (75.00%). This difference was statistically significant (χ²=6.128,P<0.05).With the increase of the b value,the apparent diffusion coefficient (ADC) values of the liver tissue and liver cancer tissue gradually decreased. Compared with normal liver tissue,the ADC value of liver cancer tissue was significantly lower than that of normal liver tissue (P<0.05). A plain MRI scan of 89 lesions,DCE examination of 93 lesions,(1)7 lesions were slow-rising and fast-falling; (2)72 lesions were fast-rising and fast-falling; (3)10 were platform-type lesions; (4)4 lesions had no enhancement. Conclusion The diagnostic efficiency of a multimodal MRI in the diagnosis of atypical HCC is high,and it has particular clinical application value.

Key words： Multimodal magnetic resonance imaging Hepatocellular carcinoma Atypical manifestations Diffusion-weighted imaging Dynamic contrast-enhanced

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Bo Li
	Naixin Wang
	Dazhi Sun
	Lixin Liu

Cite this article:

Bo Li,Naixin Wang,Dazhi Sun, et al. Application Value of Multimodal Magnetic Resonance Imaging in the Diagnosis of Atypical Hepatocellular Carcinoma[J]. Chinese Journal of Biomedical Engineering, 2020, 29(3): 33-39.

URL:

http://manu32.magtech.com.cn/Jwk_zgswyx_en/EN/ OR http://manu32.magtech.com.cn/Jwk_zgswyx_en/EN/Y2020/V29/I3/33

[1] Aliberti C,Carandina R,Sarti D,et al.Hepatic arterial infusion of polyethylene glycol drug-eluting beads for primary and metastatic liver cancer therapy[J].Ant Res,2016,36(7):3515-3521.
[2] Zheng Xiaojun,Tan Ling,Shi Gaofeng. The research value of liver enhanced CT scanning in the diagnosis of liver cancer [J].Chinese Journal of CT and MRI,2016,14(10):80-82. [Publication in Chinese]
[3] Gardini AC,Conti F,Brillanti S,et al.Imbalance of neutrophils and lymphocyte counts can be predictive of hepatocellular carcinoma occurrence in hepatitis c-related cirrhosis treated with direct-acting antivirals[J].Gastroenterology,2018,154(8):2281-2283.
[4] Yang Ming,Lu Xiaodong,he yeyin. Value analysis of liver enhanced CT and liver MRI in diagnosis of liver cancer [J].Medical Information,2016,29(1):277-278.[Publication in Chinese]
[5] Cui Y,Xu HF,Liu M Y,et al.Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value[J].World J Gastroenterol,2019,25(15):1890-1898.
[6] Maria-Angéla Castilla-Lièvre,Franco D,Gervais P,et al.Diagnostic value of combining 11 C-choline and 18 F-FDG PET/CT in hepatocellular carcinoma[J].Eur J Nuclear Med Mol Imag,2016,43(5):852-859.
[7] Wang Ke. Consistency of CT and MRI diagnostic scores for hepatocellular carcinoma in the context of hepatitis B cirrhosis: a multicenter,individual controlled study based on li-rads [J].Radiology Practice,2016,31(4):291-295.[Publication in Chinese]
[8] Sutherland T,Watts J,Ryan M,et al.Diffusion-weighted MRI for hepatocellular carcinoma screening in chronic liver disease: Direct comparison with ultrasound screening[J].J Med Imag Radiat Oncol,2017,61(1):34-39.
[9] Ailianou A,Mundada P,Perrot TD,et al.MRI with DWI for the detection of posttreatment head and neck squamous cell carcinoma: Why morphologic MRI criteria matter[J].Am J Neuroradiol,2018,39(4):748-755.
[10] Zheng Tiannian,Wu Lei. Differential diagnosis value of dynamic contrast-enhanced MRI functional imaging parameters in hepatocellular carcinoma and liver metastasis [J].Imaging Research and Medical Application,2017,1(11):93-94.[Publication in Chinese]
[11] Yue WW,Wang S,Xu HX,et al.Parametric imaging with contrast-enhanced ultrasound for differentiating hepatocellular carcinoma from metastatic liver cancer[J].Clin Hemorheol Microcircul,2016,64(2):177-179.
[12] Tamáska P,Ráski G,Pataki,et al.The role of cone-beam CT during transarterial chemoembolization for liver cancer[J].Magyar Sebeszet,2017,70(3):213-215.
[13] Kang Jing. Analysis of the effect of liver enhanced CT and liver MRI in the diagnosis of liver cancer [J].Chinese University Medical,2019,33(8):631-633.[Publication in Chinese]
[14] Lyu JY. The value of 64-slice spiral CT perfusion imaging in the treatment of liver cancer with argon-helium cryoablation[J].Oncol Lett,2016,12(6):4584-4588.
[15] Fu Zhongxiang,Wang Yi,Xu Yonghua. CT and MRI imaging diagnosis of early primary liver cancer [J].Journal of Southwest Medical University,2016,39(5):418-420.[Publication in Chinese]
[16] Johnstone E,Wyatt JJ,Henry AM,et al.Systematic review of synthetic computed tomography generation methodologies for use in magnetic resonance imaging-only radiation therapy[J].Int J Radiat Oncol Biol Phys,2018,16(17):199-217.
[17] Wu Jinmin,Wang Haibao,Xu Liyan,et al.Application value of multimodal magnetic resonance imaging in the diagnosis of breast cancer [J].Anhui Medical Journal,2017,38(8):15-17.[Publication in Chinese]
[18] Kao YCJ,Oyarzabal EA,Zhang H,et al.Role of genetic variation in collateral circulation in the evolution of acute stroke: A multimodal magnetic resonance imaging study[J].Stroke,2017,48(3):754-756.
[19] La Hai A Zhi. Comparative analysis of dynamic contrast-enhanced MRI and CT perfusion imaging in differential diagnosis of liver cancer [J].Journal of Practical Cancer,2016,16(5):855-857.[Publication in Chinese]
[20] Sweis RF,Medved M,Towey S,et al.Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic biomarker for pazopanib in metastatic renal carcinoma[J].Clin Geni Cancer,2016,15(2):1123-1125.
[21] Wang Ying,Yan Hailong,Wang Liang,et al.The value of multimodal functional MRI in the diagnosis of small hepatocellular carcinoma [J].Journal of Xinxiang Medical College,2018,35(6):521-524.[Publication in Chinese]
[22] Chehade M,Srivastava AK,Bulte JWM. Co-registration of bioluminescence tomography,computed tomography,and magnetic resonance imaging for multimodal in vivo stem cell tracking[J].Tomography,2016,2(2):159-165.
[23] Zhang Zhongnan.Differential diagnosis of multiple mode magnetic resonance imaging in glioma[J].Journal of Clinical Medicine (Electronic Edition),2016,3(5):989-991.[Publication in Chinese]
[24] Alison C,Charles M,Jenny LW. Quick brain magnetic resonance imaging with diffusion-weighted imaging as a first imaging modality in pediatric stroke[J].Pediatr Neurol,2018,78(15):55-60.
[25] Zhai Jianchun,Shi Anbin,Yang Qiuyun,et al.Analysis of CT plain scan,enhanced scan,MRI plain scan and DWI manifestations of small hepatocellular carcinoma in the background of hepatitis B cirrhosis [J].Chinese Journal of Integrated Chinese and Western Medicine Imaging,2016,14(6):643-645.[Publication in Chinese]
[26] Pickles MD,Lowry M,Gibbs P. Pretreatment prognostic value of dynamic contrast-enhanced magnetic resonance imaging vascular,texture,shape,and size parameters compared with traditional survival indicators obtained from locally advanced breast cancer patients.[J].Invest Radiol,2016,51(3):177-185.
[27] Deng J,Wang J. Correlation of dynamic contrast-enhanced magnetic resonance imaging parameters before colon cancer surgery with the angiogenesis and cell proliferation in tumor lesions[J].J Hainan Med Univers,2017,28(9):207-209.
[28] AI Zhu,Liang Qianwen,Zhong Guimian,et al.The value of multimodal imaging quantitative parameter analysis in the early diagnosis and differential diagnosis of liver cirrhosis nodule canceration [J].Radiology Practice,2017,18(9):108-111.[Publication in Chinese]
[29] Wei W,Jia G,Tengg-Kobligk HV,et al.Dynamic contrast-enhanced magnetic resonance imaging of ocular melanoma as a tool to predict metastatic potential[J].J Comput Assist Tomo,2017,41(5):364-366.
[30] Wang Jirong. The value of 1.5T enhanced magnetic resonance imaging combined with diffusion weighted imaging in the diagnosis of micro hepatocellular carcinoma [J].Qinghai Medical Journal,2017,43(7):80-82.[Publication in Chinese]
[31] Fu Nianxia,song Jianxun,Luo Zebin. Research progress of multimodal functional magnetic resonance imaging in high-grade glioma boundary [J].Journal of Lanzhou University (Medical Edition),2017,43(2):72-75.[Publication in Chinese]
[32] Bickel H,Pinker K,Polanec S,et al.Diffusion-weighted imaging of breast lesions: Region-of-interest placement and different ADC parameters influence apparent diffusion coefficient values[J].Eur Radiol,2017,27(5):1883-1892.
[33] Ebru Y,Ozcan S,Ayhan Y,et al.Diffusion-weighted imaging for the discrimination of benign and malignant breast masses; Utility of ADC and relative ADC[J].J Belg Soc Radiol,2018,102(1):21-26.
[34] Zhang Yuqin,Chen Lumiao,Jin Yao,et al.The value of multimodal magnetic resonance imaging in the evaluation of abdominal metastasis of cholangiocarcinoma [J].Chinese Journal of Gastroenterology,2018,38(12):851-853.[Publication in Chinese]
[35] Wang Xiaoqing,Wang Lei. Clinical value of dynamic contrast-enhanced MR diffusion weighted imaging in the diagnosis of benign and malignant breast lesions [J].Chinese Journal of Primary Medicine,2019,26(2):186-189.[Publication in Chinese]